| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Amneal Pharmaceuticals, Inc.
13G/A
AMRX · 03168L105
|
6.6% |
5/14/2025
Event 3/31/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.